Biotech had to deal with many blow-ups in the last week. Mast Therapeutics (MSTX) is the most notable. Novavax (NVAX) reported disappointing results for its vaccine drug. 1)Array (ARRY) may have better odds. The company will release phase III trial results this coming Friday.2)Avoid volatility ETNs. (VXX) will continue falling. The market is in a coma and has no other direction other than floating up. Friday was the exception.3)Await Google to bid for Twitter (TWTR) – unlikely.4)Expect volatility (contradicts #2 above) following U.S election debate Monday night. Big moves for stocks on Tuesday morning.5)Watch these companies reporting quarterly results: NKE, COST, BBRY, PEP, PAYX